Header Logo

Connection

THOMAS LLOYD to Sp4 Transcription Factor

Back to Details
This is a "connection" page, showing publications THOMAS LLOYD has written about Sp4 Transcription Factor.
THOMAS LLOYD
Connection Strength
0.049
Sp4 Transcription Factor
  1. Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1? autoantibodies. Ann Rheum Dis. 2023 Feb; 82(2):246-252.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.